Compounds > 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one
Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Glomerulosclerosis, Focal Segmental

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Glomerulosclerosis, Focal Segmental in 1 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Glomerulosclerosis, Focal Segmental: A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schlöndorff, J1
Del Camino, D1
Carrasquillo, R1
Lacey, V1
Pollak, MR1

Other Studies

1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Glomerulosclerosis, Focal Segmental

ArticleYear
TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription.
    American journal of physiology. Cell physiology, 2009, Volume: 296, Issue:3

    Topics: Benzylamines; Calcineurin; Calcineurin Inhibitors; Calcium; Calcium-Calmodulin-Dependent Protein Kin

2009